- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Incannex Healthcare Ltd ADR (IXHL)
NASDAQ
Currency in USD
1.930
+0.080(+4.32%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.850
1.930
52 wk Range
1.500
8.470
IXHL Income Statement
Explore the detailed Incannex Healthcare Ltd ADR income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Incannex Healthcare Ltd ADR's growth trends and overall financial health.
Advanced Income Statement
| Period Ending: | 2016 30/06 | 2017 30/06 | 2018 30/06 | 2019 30/06 | 2020 30/06 | 2021 30/06 | 2022 30/06 | 2023 30/06 | 2024 30/06 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 1.9 | 0.78 | - | 0.02 | |||||||||
Total Revenues Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +213.71% | -58.77% | - | - | |||||||||
Cost Of Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0.91 | 0.01 | - | - | |||||||||
Gross Profit | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0.99 | 0.78 | - | 0.02 | |||||||||
Gross Profit Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +537.79% | -21.26% | - | - | |||||||||
Gross Profit Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 51.94% | 99.19% | - | 100% | |||||||||
Other Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 11.17 | 12.13 | 20.45 | 27.92 | |||||||||
| ||||||||||||||||||
Operating Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -10.19 | -11.35 | -20.45 | -27.9 | |||||||||
Operating Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -168.88% | -11.44% | -80.19% | -36.42% | |||||||||
EBIT Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -536.77% | -1,450.78% | - | -155,058.33% | |||||||||
Net Interest Expenses | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0 | 0.01 | 0.36 | 0.31 | |||||||||
Net Interest Expenses Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -41.06% | +134.08% | +5,663.48% | -14.53% | |||||||||
Interest Expense, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
Interest And Investment Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0 | 0.01 | 0.36 | 0.31 | |||||||||
Other Non Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -1.19 | -3.56 | -0.1 | -0.04 | |||||||||
EBT, Excl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -11.37 | -14.9 | -20.19 | -27.63 | |||||||||
Gain (Loss) On Sale Of Assets | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
Other Unusual Items, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | -53.01 | - | |||||||||
EBT, Incl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -11.37 | -14.9 | -73.2 | -27.63 | |||||||||
EBT, Incl. Unusual Items Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -189.44% | -31.05% | -391.16% | +62.25% | |||||||||
EBT, Incl. Unusual Items Margin | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -599.33% | -1,904.94% | - | -153,575% | |||||||||
Income Tax Expense | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | 0.04 | |||||||||
Net Income to Company | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -11.37 | -14.9 | -73.2 | -27.68 | |||||||||
Minority Interest | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
Net Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -11.37 | -14.9 | -73.2 | -27.68 | |||||||||
Net Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -142.1% | -31.05% | -391.16% | +62.19% | |||||||||
Net Income Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -599.33% | -1,904.94% | - | -153,825% | |||||||||
Preferred Dividend and Other Adjustments | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
Net Income to Common Excl. Extra Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -11.37 | -14.9 | -73.2 | -27.68 | |||||||||
Basic EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -0.05 | -0.05 | -4.76 | -1.71 | |||||||||
Basic EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -102.66% | -7.48% | -9,407.06% | +64.01% | |||||||||
Diluted EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -0.05 | -0.05 | -4.76 | -1.71 | |||||||||
Diluted EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -102.66% | -7.48% | -9,407.06% | +64.01% | |||||||||
Basic Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 244.23 | 297.79 | 23.07 | 24.24 | |||||||||
Diluted Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 244.23 | 297.79 | 23.07 | 24.24 | |||||||||
Dividend Per Share | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
Dividend Per Share Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | |||||||||
EBITDA | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | -20.42 | -27.75 | |||||||||
EBITDA Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | -35.89% | |||||||||
EBITDA Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | -154,200% | |||||||||
EBIT | aa.aa | aa.aa | aa.aa | aa.aa | ||||||||||||||